MCID: MLG098
MIFTS: 37

Malignant Mixed Mullerian Tumor

Categories: Rare diseases, Cancer diseases

Aliases & Classifications for Malignant Mixed Mullerian Tumor

MalaCards integrated aliases for Malignant Mixed Mullerian Tumor:

Name: Malignant Mixed Mullerian Tumor 49
Carcinosarcoma 49 51 69
Mixed Tumor, Mullerian 49 69
Mixed Tumor, Not Otherwise Specified 69
Malignant Mixed Mesodermal Tumor 69
Mixed Mullerian Tumor 49
Mixed Tumor Mullerian 51
Mmmt 49

Classifications:



External Ids:

Summaries for Malignant Mixed Mullerian Tumor

NIH Rare Diseases : 49 A malignant mixed müllerian tumor (MMMT), also called a carcinosarcoma, is a type of cancer that contains two types of cells, known as the adenocarcinoma and sarcoma types. These tumors usually develop in tissues of the female genital tract and are associated with a poor outcome. The majority of these tumors arise in the uterus, though they can also occur in the ovaries, fallopian tubes, and cervix. Very rarely, MMMTs can develop in the female peritoneum (lining of the abdominal wall). Last updated: 12/6/2011

MalaCards based summary : Malignant Mixed Mullerian Tumor, also known as carcinosarcoma, is related to papillary serous adenocarcinoma and ovarian cancer 1. An important gene associated with Malignant Mixed Mullerian Tumor is VIM (Vimentin), and among its related pathways/superpathways is Cytoskeletal Signaling. The drugs Paclitaxel and Carboplatin have been mentioned in the context of this disorder. Affiliated tissues include uterus, ovary and cervix.

Related Diseases for Malignant Mixed Mullerian Tumor

Diseases related to Malignant Mixed Mullerian Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 217)
# Related Disease Score Top Affiliating Genes
1 papillary serous adenocarcinoma 30.0 KRT7 PGR
2 ovarian cancer 1 29.5 KRT7 MUC1 PGR
3 ovarian carcinosarcoma 11.9
4 cervical carcinosarcoma 11.2
5 vaginal carcinosarcoma 11.2
6 fallopian tube carcinosarcoma 11.2
7 malignant peritoneal mesothelioma 10.3 MUC1 VIM
8 papillary tumor of the pineal region 10.3 MUC1 VIM
9 adenoid squamous cell carcinoma 10.3 KRT7 VIM
10 ossifying fibromyxoid tumor 10.3 MUC1 VIM
11 biphasic synovial sarcoma 10.3 MUC1 VIM
12 fibrous meningioma 10.3 MUC1 VIM
13 chordoid meningioma 10.3 MUC1 VIM
14 papillary adenoma 10.3 KRT7 VIM
15 syringocystadenoma papilliferum 10.3 MUC1 VIM
16 adenofibroma 10.3 MUC1 VIM
17 myxopapillary ependymoma 10.3 MUC1 VIM
18 sarcomatoid mesothelioma 10.2 MUC1 VIM
19 syringoma 10.2 MUC1 VIM
20 anaplastic ependymoma 10.2 MUC1 VIM
21 medulloepithelioma 10.2 KRT7 VIM
22 metanephric adenoma 10.2 KRT7 VIM
23 pleomorphic liposarcoma 10.2 MUC1 VIM
24 adenomatoid tumor 10.2 KRT7 VIM
25 reticulum cell sarcoma 10.2 MUC1 VIM
26 sertoli cell tumor 10.2 MUC1 VIM
27 chondroid chordoma 10.2 MUC1 VIM
28 fibrolamellar carcinoma 10.2 KRT7 VIM
29 mesenchymal chondrosarcoma 10.2 MUC1 VIM
30 extraskeletal ewing sarcoma 10.2 MUC1 VIM
31 endocervical adenocarcinoma 10.2 KRT7 VIM
32 endodermal sinus tumor 10.2 KRT7 VIM
33 middle ear adenoma 10.2 KRT7 MUC1
34 glandular cystitis 10.2 KRT7 MUC1
35 bile duct mucoepidermoid carcinoma 10.2 KRT7 MUC1
36 collecting duct carcinoma 10.2 KRT7 VIM
37 mucinous bronchioloalveolar adenocarcinoma 10.2 KRT7 MUC1
38 dendritic cell tumor 10.2 MUC1 VIM
39 bile duct cystadenocarcinoma 10.2 KRT7 MUC1
40 granulosa cell tumor of the ovary 10.2 KRT7 VIM
41 nephrogenic adenoma 10.2 KRT7 MUC1
42 cerebral primitive neuroectodermal tumor 10.2 MUC1 VIM
43 adenomyoma 10.2 KRT7 MUC1
44 hemangiopericytoma, malignant 10.2 MUC1 VIM
45 mucinous ovarian cystadenoma 10.2 KRT7 MUC1
46 lymphangiomatosis 10.2 PGR VIM
47 hidradenocarcinoma 10.2 KRT7 VIM
48 well-differentiated liposarcoma 10.2 KRT7 MUC1
49 paget disease, extramammary 10.2 KRT7 MUC1
50 epulis 10.2 PGR VIM

Graphical network of the top 20 diseases related to Malignant Mixed Mullerian Tumor:



Diseases related to Malignant Mixed Mullerian Tumor

Symptoms & Phenotypes for Malignant Mixed Mullerian Tumor

Drugs & Therapeutics for Malignant Mixed Mullerian Tumor

Drugs for Malignant Mixed Mullerian Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 97)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Paclitaxel Approved, Vet_approved Phase 3,Phase 2,Phase 1 33069-62-4 36314
2
Carboplatin Approved Phase 3,Phase 2,Phase 1 41575-94-4 10339178 38904 498142
3
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
4
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
5
Ifosfamide Approved Phase 3,Phase 2 3778-73-2 3690
6
Mechlorethamine Approved, Investigational Phase 3,Phase 2 51-75-2 4033
7
Mesna Approved, Investigational Phase 3,Phase 2 3375-50-6 598
8
Lenograstim Approved, Investigational Phase 3,Phase 1 135968-09-1
9
Bevacizumab Approved, Investigational Phase 3,Phase 2,Phase 1 216974-75-3
10
Histamine Approved, Investigational Phase 3 51-45-6, 75614-87-8 774
11
Cyproheptadine Approved Phase 3 129-03-3 2913
12
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
13 Alkylating Agents Phase 3,Phase 2
14 Albumin-Bound Paclitaxel Phase 3,Phase 2,Phase 1
15 Antimitotic Agents Phase 3,Phase 2,Phase 1
16 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1
17 Isophosphamide mustard Phase 3,Phase 2 0
18 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
19 Angiogenesis Inhibitors Phase 3,Phase 2,Phase 1
20 Angiogenesis Modulating Agents Phase 3,Phase 2,Phase 1
21 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
22 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
23
Histamine Phosphate Phase 3 51-74-1 65513
24
Serotonin Phase 3 50-67-9 5202
25 Serotonin Agents Phase 3
26 Serotonin Antagonists Phase 3
27 Gastrointestinal Agents Phase 3
28 Neurotransmitter Agents Phase 3
29 Histamine Antagonists Phase 3
30 Histamine H1 Antagonists Phase 3
31 Dermatologic Agents Phase 3
32 Anti-Allergic Agents Phase 3
33 Antipruritics Phase 3
34
Gemcitabine Approved Phase 2 95058-81-4 60750
35
Dacarbazine Approved, Investigational Phase 2 4342-03-4 5351166
36
Temozolomide Approved, Investigational Phase 2 85622-93-1 5394
37
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
38
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
39
Cetuximab Approved Phase 2 205923-56-4 56842117 2333
40
Oxaliplatin Approved, Investigational Phase 2 61825-94-3 43805 6857599 5310940 9887054
41
Everolimus Approved Phase 2 159351-69-6 6442177
42
Sunitinib Approved, Investigational Phase 2 341031-54-7, 557795-19-4 5329102
43
Sirolimus Approved, Investigational Phase 2 53123-88-9 46835353 6436030 5284616
44
Trabectedin Approved, Investigational Phase 2 114899-77-3 108150
45
Metformin Approved Phase 2 657-24-9 4091 14219
46
Doxycycline Approved, Investigational, Vet_approved Phase 2 564-25-0 54671203
47
nivolumab Approved Phase 2 946414-94-4
48
Topotecan Approved, Investigational Phase 2 119413-54-6, 123948-87-8 60700
49
Niacin Approved, Investigational, Nutraceutical Phase 2 59-67-6 938
50
Nicotinamide Approved, Investigational, Nutraceutical Phase 2 98-92-0 936

Interventional clinical trials:

(show top 50) (show all 73)

# Name Status NCT ID Phase Drugs
1 Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus Completed NCT00003128 Phase 3 ifosfamide;paclitaxel
2 Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus Completed NCT00002546 Phase 3 cisplatin;ifosfamide
3 Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus Completed NCT00002459 Phase 3
4 Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer Completed NCT00483782 Phase 3 carboplatin;paclitaxel
5 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00002641 Phase 3 doxorubicin hydrochloride;ifosfamide;isolated perfusion
6 Short Course Vaginal Cuff Brachytherapy in Treating Patients With Stage I-II Endometrial Cancer Recruiting NCT03422198 Phase 3
7 Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer Active, not recruiting NCT00954174 Phase 3 Carboplatin;Ifosfamide;Paclitaxel
8 Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Terminated NCT01132547 Phase 3 cyproheptadine hydrochloride
9 Pazopanib vs. Pazopanib Plus Gemcitabine in Patients With Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble - Unknown status NCT02203760 Phase 2 Pazopanib plus Gemcitabine;Pazopanib
10 Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Unknown status NCT00838656 Phase 2 carboplatin;gemcitabine hydrochloride;paclitaxel
11 Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma Unknown status NCT00003718 Phase 2 temozolomide
12 Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus Completed NCT00502203 Phase 2 Carboplatin;Paclitaxel
13 Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma Completed NCT00687687 Phase 2 paclitaxel;carboplatin;BSI-201 (Iniparib)
14 Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus Completed NCT00476086 Phase 2 Gemcitabine;Oxaliplatin
15 Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus Completed NCT00025506 Phase 2 Thalidomide
16 Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors Completed NCT00520013 Phase 2 bevacizumab;erlotinib;paclitaxel;carboplatin
17 Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer Completed NCT01247571 Phase 2 Pazopanib Hydrochloride
18 Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer Completed NCT00114218 Phase 2 Gemcitabine Hydrochloride;Docetaxel
19 Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer Completed NCT00075400 Phase 2 imatinib mesylate
20 A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide in Patients With MMT of the Uterus Completed NCT00231842 Phase 2 Ifosfamide
21 Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer Completed NCT00238121 Phase 2 sorafenib tosylate
22 Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors Completed NCT00815945 Phase 2 PegLiposomal Doxorubicin;Carboplatin
23 Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer Completed NCT00112489 Phase 2 carboplatin;paclitaxel
24 Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma Completed NCT00390234 Phase 2 ziv-aflibercept
25 Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer Completed NCT00511992 Phase 2 Avastin;Paclitaxel;Cisplatin
26 A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma Completed NCT00231868 Phase 2 Carboplatin and Paclitaxel and Pelvic Radiation Therapy;Carboplatin and Paclitaxel and Radiation Therapy
27 Carboplatin Taxol Avastin in Ovarian Cancer (OVCA) Completed NCT00129727 Phase 2 Paclitaxel;Carboplatin;Bevacizumab
28 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Completed NCT00474994 Phase 2 sunitinib malate
29 Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer Completed NCT01010126 Phase 2 Temsirolimus
30 AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00659360 Phase 2 saracatinib
31 Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma Completed NCT00245102 Phase 2 sorafenib tosylate
32 Chemotherapy in Treating Patients With Sarcoma of the Uterus Completed NCT00005643 Phase 2 pegylated liposomal doxorubicin hydrochloride
33 Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract Completed NCT00003334 Phase 2 paclitaxel;pegylated liposomal doxorubicin hydrochloride
34 BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors Completed NCT00526149 Phase 2 BI 2536
35 Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00003939 Phase 2 trabectedin
36 STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma Completed NCT00006357 Phase 1, Phase 2 imatinib mesylate
37 Thalidomide in Treating Patients With Gynecologic Sarcomas Completed NCT00006005 Phase 2 thalidomide
38 Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer Completed NCT00032162 Phase 1, Phase 2 carboplatin;pegylated liposomal doxorubicin hydrochloride
39 Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer Completed NCT00392769 Phase 2 Cetuximab
40 A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer Recruiting NCT03015129 Phase 2 Durvalumab;Tremelimumab
41 A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers Recruiting NCT02923934 Phase 2 Ipilimumab;Nivolumab
42 Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer Recruiting NCT02874430 Phase 2 Metformin Hydrochloride;Doxycycline
43 A Study of Nivolumab in Selected Uterine Cancer Patients Recruiting NCT03241745 Phase 2 Nivolumab
44 Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Recruiting NCT02101775 Phase 2 Gemcitabine Hydrochloride;WEE1 Inhibitor AZD1775
45 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting NCT02834013 Phase 2
46 Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer Active, not recruiting NCT01168232 Phase 2 ixabepilone
47 Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer Active, not recruiting NCT00416455 Phase 1, Phase 2 ferumoxtran-10
48 Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer Active, not recruiting NCT00478426 Phase 2 Sunitinib Malate
49 Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)_MITO 26 Not yet recruiting NCT02993705 Phase 2 Trabectedin
50 Cabozantinib-S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer Suspended NCT01935934 Phase 2 Cabozantinib S-malate

Search NIH Clinical Center for Malignant Mixed Mullerian Tumor

Genetic Tests for Malignant Mixed Mullerian Tumor

Anatomical Context for Malignant Mixed Mullerian Tumor

MalaCards organs/tissues related to Malignant Mixed Mullerian Tumor:

38
Uterus, Ovary, Cervix, Prostate, Liver, Lymph Node, Endothelial

Publications for Malignant Mixed Mullerian Tumor

Articles related to Malignant Mixed Mullerian Tumor:

(show top 50) (show all 56)
# Title Authors Year
1
Malignant mixed mullerian tumor of ovary-scrape cytology: Findings with review of literature. ( 28469326 )
2017
2
Extremely Locally Advanced Ovarian Malignant Mixed Mullerian Tumor in 37-Years-Old Female. ( 28593890 )
2017
3
Serous Carcinoma component championed by Heparin Binding-EGF Like Growth Factor (HB-EGF) Predisposing to Metastasis and Recurrence in Stage I Uterine Malignant Mixed Mullerian Tumor. ( 26980026 )
2016
4
Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor. ( 26711836 )
2015
5
Extragenital malignant mixed Mullerian tumor in the incisional hernia - primary carcinosarcoma in the abdominal wall: case report. ( 26012132 )
2015
6
Serous Ovarian Carcinoma Recurring as Malignant Mixed Mullerian Tumor. ( 26713165 )
2015
7
F-18 fluorodeoxyglucose positron emission tomography/computed tomography in a rare case of recurrent malignant mixed mullerian tumor. ( 25191116 )
2014
8
Endometrioid carcinoma infiltrating atypical leiomyoma: a mimicker of malignant mixed Mullerian tumor. ( 24943777 )
2014
9
Malignant mixed mullerian tumor of the ovary. ( 25404814 )
2014
10
Prolonged survival of a patient with pelvic recurrence of ovarian malignant mixed mullerian tumor after chemoradiotherapy. ( 25593719 )
2014
11
ANNA-1 (anti-Hu) associated sensory neuronopathy with malignant mixed mullerian tumor. ( 23536385 )
2013
12
Malignant mixed mullerian tumor of endometrium coexisting with bilateral papillary serous adenocarcinoma of fallopian tube: a rare case report. ( 24293882 )
2012
13
Malignant mixed mullerian tumor: an immunohistochemical study. ( 22848863 )
2012
14
Malignant mixed Mullerian tumor of the ovary with two cases and review of the literature. ( 21298439 )
2011
15
Malignant mixed Mullerian tumor of broad ligament with synchronous ovarian and endometrial carcinoma: a rare association. ( 21546752 )
2011
16
Ovarian malignant mixed mullerian tumor with primitive neuroectodermal differentiation: case report with review of the literature. ( 20950943 )
2011
17
Uncommon manifestations of Endocervical Malignant Mixed Mullerian Tumor with Incidental Bilateral Fallopian Tube Carcinoma. ( 21701666 )
2011
18
Malignant mixed mullerian tumor of the cervix including components of a rhabdomyosarcoma: case report and literature review. ( 20882897 )
2010
19
Intracardiac metastasis of a Malignant Mixed Mullerian tumor (MMMT): progressive dyspnoea due to obstruction of the left atrium and the left ventricle without left ventricular dysfunction or primary lung disease. ( 19652943 )
2009
20
Homologous type of malignant mixed Mullerian tumor of the uterus presenting as a cervical mass. ( 19837648 )
2009
21
Bilateral ovarian malignant mixed Mullerian tumor in a dog. ( 19176505 )
2009
22
Biopsy-proven cerebellar metastasis from a malignant mixed mullerian tumor (MMMT) of the uterus: case report. ( 19480254 )
2009
23
Extra genital heterologous malignant mixed mullerian tumor of primary peritoneal origin. ( 19136793 )
2009
24
Comparative analysis of P16 and P53 expression in uterine malignant mixed mullerian tumors. ( 19851197 )
2009
25
CT imaging of a primary malignant mixed mullerian tumor arising from the peritoneum. ( 18760728 )
2008
26
Malignant mixed mullerian tumor of the urinary bladder in a 73 year old woman. ( 18559304 )
2008
27
Primary malignant mixed mullerian tumor of the uterus: findings on sonography, CT, and gadolinium-enhanced MRI. ( 18562759 )
2008
28
Malignant mixed mullerian tumor of the vagina: case report with review of the literature, immunohistochemical study, and evaluation for human papilloma virus. ( 17640554 )
2007
29
Diagnostic dilemma in a case of malignant mixed mullerian tumor of the cervix. ( 16813659 )
2006
30
Primary malignant mixed Mullerian tumor arising in the rectosigmoid. ( 16612719 )
2006
31
Malignant mixed mullerian tumor in a rabbit (Oryctolagus cuniculus): case report with immunohistochemistry. ( 16847001 )
2006
32
Pancreatic metastasis of an ovarian malignant mixed Mullerian tumor identified by EUS-guided fine needle aspiration and Trucut needle biopsy. ( 16407622 )
2006
33
Paraneoplastic subacute sensory neuronopathy secondary to a malignant mixed mullerian tumor. ( 16449165 )
2006
34
Malignant mixed mullerian tumor of the uterus in a patient taking raloxifene. ( 15863610 )
2005
35
Primary peritoneal carcinosarcoma (malignant mixed mullerian tumor): Report of a case with five-year disease free survival after surgery and chemoradiation and a review of literature. ( 16227168 )
2005
36
Primary malignant mixed mullerian tumor of the vagina immunohistochemically confirmed. ( 14735374 )
2005
37
Presentation with superior vena cava syndrome secondary to solitary lung metastasis mimicking primary lung cancer following resection of a uterine malignant mixed mullerian tumor: brief case report. ( 15653218 )
2005
38
Malignant mixed mullerian tumor (MMMT) of the cervix. ( 15863143 )
2005
39
Malignant mixed Mullerian tumor of the fimbriated end of the fallopian tube: origin as an intraepithelial carcinoma. ( 15790462 )
2005
40
Comment on "Malignant mixed Mullerian tumor of the ovary: an argument for BRCA3 or a coincidental cluster of unconnected cancer". ( 15582005 )
2004
41
Malignant mixed Mullerian tumor of the ovary growing into an inguinal hernia sac: report of a case. ( 14513334 )
2003
42
Malignant mixed mullerian tumor of the ovary and bilateral breast cancer: an argument for BRCA3, or a coincidental cluster of unconnected cancers? ( 14599878 )
2003
43
Malignant mixed Mullerian tumor of the uterine corpus with alpha-fetoprotein-producing hepatoid adenocarcinoma component. ( 14599882 )
2003
44
Malignant mixed Mullerian tumor of the uterine cervix with neuroendocrine differentiation. ( 11975686 )
2002
45
Malignant mixed mullerian tumor of the ovary: report of four cases. ( 11321500 )
2001
46
Good response of malignant mixed mullerian tumor of the ovary to paclitaxel and cisplatin chemotherapy. ( 10609493 )
1999
47
Malignant Mixed Mullerian Tumor of the Extra-genital Coelomic Epithelium: Report of Two Cases. ( 11173640 )
1997
48
Myasthenia gravis associated with malignant mixed Mullerian tumor of the uterus. ( 9062162 )
1997
49
Malignant mixed mullerian tumor of the female peritoneum: treatment and outcome of three cases. ( 9190987 )
1997
50
Extragenital malignant mixed mullerian tumor. ( 8386082 )
1993

Variations for Malignant Mixed Mullerian Tumor

Expression for Malignant Mixed Mullerian Tumor

Search GEO for disease gene expression data for Malignant Mixed Mullerian Tumor.

Pathways for Malignant Mixed Mullerian Tumor

Pathways related to Malignant Mixed Mullerian Tumor according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.29 KRT7 MUC1 VIM

GO Terms for Malignant Mixed Mullerian Tumor

Sources for Malignant Mixed Mullerian Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....